Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Abstract Background Stereotactic Body Radiation Therapy (SBRT) is an innovative modality based on high precision planning and delivery. Cancer with bone metastases and oligometastases are associated with an intermediate or good prognosis. We assume that prolonged survival rates would be achieved if...

Full description

Bibliographic Details
Main Authors: Sébastien Thureau, Vincent Marchesi, Marie-Hélène Vieillard, Lionel Perrier, Albert Lisbona, Marianne Leheurteur, Jean Tredaniel, Stéphane Culine, Bernard Dubray, Naïma Bonnet, Bernard Asselain, Julia Salleron, Jean-Christophe Faivre
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
MeSH: Oligometastases
Bone metastases
Stereotactic radiotherapy
Neoplasm metastasis
Radiosurgery
Lung neoplasms
Online Access:https://doi.org/10.1186/s12885-021-07828-2

Internet

https://doi.org/10.1186/s12885-021-07828-2

Similar Items